Is a complete MXCT research report available?

No complete published report is available for MaxCyte, Inc. (MXCT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

MaxCyte, Inc. (MXCT)

NASDAQ: MXCT · USD

$1.05

+0.04 (+4.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MXCT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	112.5M
Revenue (ttm)	32.3M
Net income (ttm)	-39.1M
EPS (ttm)	-$0.37
Shares out	107.1M
Volume	312,588
Beta	1.66
Price target	$4.11	+291.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 32.3M
Net income (ttm): -39.1M
EPS (ttm): -$0.37
Market cap: 112.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MXCT indicators

Market & fundamental data

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001287098
Company name	MaxCyte, Inc.
Country	United States
Country code	US
Cusip	57777K106
Employees	91
Employees Change	-23%
Employees Change Percent	-20.18
Enterprise value	$23.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	41
Industry PE Fwd	19.92
IPO Date	2021-07-30
Isin	US57777K1060
Last refreshed	2026-07-31
Market cap	$112.5M
Market cap category	Micro-Cap
Price	$1.05
Price currency	USD
Rev Per Employee	354,802.2x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	8731
Symbol	MXCT
Website	https://www.maxcyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-34.61%
EV Sales Forward	0.8x
EV/Sales	0.73x
FCF yield	-25.97%
P/B ratio	0.64x
P/S ratio	3.5x
PS Forward	3.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-141.81%
EBITDA Margin	-128.52%
Gross margin	80.51%
Gross Profit	$26M
Gross Profit Growth	-14.72%
Gross Profit Growth Q	-9.12%
Gross Profit Growth3 Y	-10.47%
Gross Profit Growth5 Y	1.51%
Net Income	$-39.1M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-121.16%
Profit Margin	-121.16%
Profit Per Employee	$-429,879
ROA	-11.32
Roa5y	-9.76
ROCE	-24.85
ROE	-21.3
Roe5y	-15.99
ROIC	-11.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-50.5%
Cagr3y	-38.34%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	-14.3x
Revenue Growth Q	-7.11x
Revenue Growth Years	0x
Revenue Growth3 Y	-7.84x
Revenue Growth5 Y	3.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.15
Assets	$194.5M
Cash	$106.9M
Current Assets	$122.9M
Current Liabilities	$10.2M
Debt	$17.5M
Debt Equity	$0.1
Equity	$167.9M
Liabilities	$26.6M
Long Term Assets	$71.5M
Long Term Liabilities	$16.4M
Net Cash	$89.4M
Net Cash By Market Cap	$79.08
Net Cash Growth	-25.18%
Net Debt Equity	$-0.53
Tangible Book Value	$167.1M
Tangible Book Value Per Share	$1.56
WACC	11.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.04
Inventory Turnover	0.79
Net Working Capital	$7.2M
Quick ratio	10.88
Working Capital	$112.7M
Working Capital Turnover	$0.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.28%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-50.47%
200-day SMA	1.17
3Y total return	-76.56%
50-day SMA	1.18
50-day SMA vs 200-day SMA	50over200
All Time High	17.44
All Time High Change	-93.98%
All Time High Date	2021-07-30
All Time Low	0.64
All Time Low Change	63.2%
All Time Low Date	2026-02-17
ATR	0.08
Beta	1.66
Beta1y	1.55
Beta2y	1.16
Ch YTD	-32.26
High	1.06
High52	2.19
High52 Date	2025-08-05
High52ch	-52.05%
Low	1
Low52	0.64
Low52 Date	2026-02-17
Low52ch	63.2%
Ma50ch	-11.24%
Premarket Change Percent	5.94
Premarket Price	$1.07
Premarket Volume	2,601
Price vs 200-day SMA	-10.1%
RSI	39.16
RSI Monthly	33.69
RSI Weekly	46.21
Sharpe ratio	-0.62x
Sortino ratio	-0.78
Total Return	-1.28%
Tr YTD	-32.26
Tr1m	-15.32%
Tr1w	-6.25%
Tr3m	28.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	2
Analyst Price Target Top	$4
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.1
Earnings Revenue Estimate	6,675,920x
Earnings Revenue Estimate Growth	-21.52x
Operating Income	$-38.4M
Operating margin	-119
Price target	$4.11
Price Target Change	$291
Price Target Change Top	$281

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,632,280%
Float Percent	91.14%
Shares Insiders	1.2%
Shares Institutions	62.89%
Shares Out	107,121,672
Shares Qo Q	0.13%
Shares Yo Y	1.28%
Short Float	1.44%
Short Ratio	0.82
Short Shares	1.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-36.7M
Adjusted OCF	-35,483,000
Average Volume	1,021,252.05x
Bv Per Share	1.57
CAPEX	$-1.2M
Ch1m	-15.32
Ch1w	-6.25
Ch1y	-50.47
Ch3m	28.43
Ch3y	-76.56
Ch6m	7.07
Change	3.96%
Change From Open	5.53
Close	1.01
Days Gap	-1.49
Depreciation Amortization	4,263,000
Dollar Volume	328,217.4
Earnings Date	2026-08-12
Earnings Time	amc
EBIT	$-45.8M
EBITDA	$-41.5M
EPS	$-0.37
F Score	1
FCF	$-29.4M
FCF EV Yield	-124.14x
FCF Per Share	$-0.27
Financing CF	278,000
Fiscal Year End	December
Founded	1,999
Investing CF	19,062,000
Ipr	-91.88
Iprfo	-93.79
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-25
Ma150	1.03
Ma150ch	2.44%
Ma20	1.22
Ma20ch	-13.72%
Net CF	-8,828,000
Next Earnings Date	2026-08-12
Open	1
Optionable	Yes
Position In Range	84.62
Post Close	1.05
Postmarket Change Percent	0.12
Postmarket Price	$1.05
Ppne	27,336,000
Pre Close	1.01
Price Date	2026-07-30
Ptbv Ratio	0.68
Relative Volume	0.31x
Revenue	32,287,000x
SBC By Revenue	22.66x
Share Based Comp	7,315,000
Tr6m	7.07%
Us State	Maryland
Volume	312,588
Z Score	2.32

MaxCyte, Inc. (MXCT)

Coverage state: Market snapshot only — no published research

Generate the first MXCT analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · MXCT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MXCT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MXCT

Frequently asked questions